Pear Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 2.15, indicating more challenging environment then in the third quarter 2022, but still, it is a far cry from any concerns. Pear Therapeutics Inc 's Accounts Receivable average collection period in the Dec 31 2022 quarter, has increased to 170 days, from 147 days, in the Sep 30 2022 quarter.

If we take a look into Healthcare sector 585 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 3944, from overall ranking in the third quarter 2022 at 3950.

What is Receivable Turnover Ratio?
What is Pear Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PEAR Receivables Turnover Ratio	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter
Y / Y Receivable Change	287.01 %	-	-	-	598.05 %
Y / Y Revenue Change	94.32 %	211.44 %	174.52 %	631.12 %	-
Receivable Turnover Ratio (TTM)	2.15	2.48	3.07	4.44	9.38
PEAR's Total Ranking	# 3944	# 3950	# 3060	# 0	# 0
Accounts Receivable average collection period days	170	147	119	82	39
Seq. Receivable Change	-3.34 %	33.59 %	30.16 %	130.27 %	-
Seq. Revenue Change	-37.18 %	23.84 %	19.93 %	108.26 %	0.69 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 184
Healthcare Sector	# 586
Overall Market	# 3944

Receivable Turnover Ratio Statistics
High	Average	Low
0.1	0.09	0.09
(Dec 31 2022)		(Sep 30 2022)

PEAR Company Profile • Back to PEAR Efficiency Comparisons • Compare PEAR Receivables Turnover Ratio to its Competitors

Financial Statements
Pear Therapeutics Inc 's Accounts Receivable	$ 7 Millions	Visit PEAR's Balance sheet
Pear Therapeutics Inc 's Sales TTM	$ 13 Millions	Visit PEAR's Income Statement
Sources of PEAR's Revenues		Visit PEAR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PEAR's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PEAR's Growth Rates	PEAR's Roa	PEAR's Inventory Turnover Ratio	PEAR's Dividend Comparisons
PEAR's Profitability Ratios	PEAR's Roi	PEAR's Asset Turnover Ratio	PEAR's Dividend Growth
PEAR's Valuation Ratios	PEAR's Roe	PEAR's Financial Strength Ratios	PEAR's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2022	Receivable at quarter ending Dec 31 2022
Ptc Therapeutics inc	5.02	$ 698.801 Millions	$ 139.325 Millions
Exagen Inc	5.01	$ 45.563 Millions	$ 9.086 Millions
Relay Therapeutics Inc	5.00	$ 1.381 Millions	$ 0.276 Millions
Innovative Eyewear Inc	5.00	$ 0.660 Millions	$ 0.132 Millions
Staar Surgical Co	4.99	$ 284.391 Millions	$ 56.940 Millions
Thermogenesis Holdings Inc	4.99	$ 10.483 Millions	$ 2.101 Millions
Neurocrine Biosciences Inc	4.99	$ 1,488.700 Millions	$ 298.425 Millions
Healthcare Services Group Inc	4.99	$ 1,690.176 Millions	$ 338.946 Millions
Bristol myers Squibb Company	4.98	$ 46,159.000 Millions	$ 9,266.000 Millions
Precigen Inc	4.97	$ 53.417 Millions	$ 10.749 Millions
Mirum Pharmaceuticals Inc	4.96	$ 77.062 Millions	$ 15.548 Millions
Guardant Health Inc	4.95	$ 449.538 Millions	$ 90.766 Millions
Amgen Inc	4.94	$ 26,323.000 Millions	$ 5,323.250 Millions
Asensus Surgical Inc	4.94	$ 7.087 Millions	$ 1.434 Millions
Labcorp Holdings Inc	4.92	$ 14,876.800 Millions	$ 3,020.875 Millions
Cvrx inc	4.90	$ 22.129 Millions	$ 4.519 Millions
Dynavax Technologies Corporation	4.89	$ 721.683 Millions	$ 147.453 Millions
Tactile Systems Technology Inc	4.89	$ 246.785 Millions	$ 50.431 Millions
Dexcom Inc	4.88	$ 2,909.800 Millions	$ 595.675 Millions
Astrotech Corp	4.88	$ 0.422 Millions	$ 0.087 Millions
Catalent Inc	4.87	$ 4,731.000 Millions	$ 972.000 Millions
Endo International Plc	4.86	$ 2,318.875 Millions	$ 476.853 Millions
Pharming Group N v	4.86	$ 205.622 Millions	$ 42.326 Millions
Lantheus Holdings Inc	4.86	$ 935.061 Millions	$ 192.502 Millions
Reshape Lifesciences Inc	4.85	$ 11.240 Millions	$ 2.317 Millions
Talis Biomedical Corporation	4.84	$ 4.812 Millions	$ 0.994 Millions
Artivion Inc	4.83	$ 313.789 Millions	$ 64.938 Millions
Evoke Pharma Inc	4.81	$ 2.509 Millions	$ 0.521 Millions
Agios Pharmaceuticals Inc	4.81	$ 14.240 Millions	$ 2.961 Millions
Bicycle Therapeutics Plc	4.80	$ 14.463 Millions	$ 3.011 Millions

Date modified: 2026-06-22T16:30:30+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.